Format (l x h) : 210 x 280 mm
| Editeur : ELSEVIER
| Date de publication : 01/1956
| Nombre de volume : 198 volume(s)
| Périodicité : 10 n° par an
| Langue(s) de publication : Anglais
An international multidisciplinary journal with two objectives :- to create an interface between clinical and laboratory responses to drugs and to investigate critical approaches to different pathologies with regard to biological and clinical data,- ...en savoir plus
An international multidisciplinary journal with two objectives :- to create an interface between clinical and laboratory responses to drugs and to investigate critical approaches to different pathologies with regard to biological and clinical data,- to provide a niche for authors whose work is not directly defined by the review criteria of existing journals. Biomedicine and pharmacotherapy is one of the few journals at the forefront of fundamental and technical science, biological and medical disciplines, therapeutics and pathological description. General fields of interest include molecular and cell biology, genetic disease, immunology and immunoregulation and chemotherapy. Special emphasis is placed on studies of specific topics such as differentiation, pharmacology and toxicology, preclinical and clinical pharmacology, the effects of drugs on cell structural and functional elements, the mechanism of gene regulation in normal and pathological cells, the role of viruses and parasites and the therapy of the diseases they induce. Brief reports of meetings, symposia and conferences will also be considered for publication as well as announcements of scientific meetings or academic courses.
An international multidisciplinary journal with two objectives :- to create an interface between clinical and laboratory responses to drugs and to investigate critical approaches to different pathologies with regard to biological and clinical data,- to provide a niche for authors whose work is not directly defined by the review criteria of existing journals. Biomedicine and pharmacotherapy is one of the few journals at the forefront of fundamental and technical science, biological and medical disciplines, therapeutics and pathological description. General fields of interest include molecular and cell biology, genetic disease, immunology and immunoregulation and chemotherapy. Special emphasis is placed on studies of specific topics such as differentiation, pharmacology and toxicology, preclinical and clinical pharmacology, the effects of drugs on cell structural and functional elements, the mechanism of gene regulation in normal and pathological cells, the role of viruses and parasites and the therapy of the diseases they induce. Brief reports of meetings, symposia and conferences will also be considered for publication as well as announcements of scientific meetings or academic courses.
Sommaire du dernier numéro paru:
Editorial Board
Targeted cytosolic delivery of mRNA immunotherapeutics: From vaccine delivery to protein replacement
Immune checkpoint targeted drug conjugate therapies: Bridging preclinical and clinical innovation for solid tumor therapy
Beyond total release: Fragment-resolved metrics for ultrasound microbubble-mediated drug delivery
Targeting NLRP3 inflammasome signaling for atrial fibrillation therapy
Cell death in kidney transplantation: Mechanisms and therapeutic perspectives
Advancing adoptive cellular immunotherapy via Notch-based ex vivo T cell development platforms
Adipose stem cell-derived exosomes as emerging neurotherapeutics in obesity induced diabetic neuropathy
Lipidomic insights into infectious meningitis: Pathogen-specific alterations and therapeutic implications
Injectable thermosensitive hydrogel-based sustained delivery system for anti-diabetic peptides in type 2 diabetes mellitus therapy: A review
The trophoblastic theory of cancer: Progesterone-dependent immune tolerance and modulation by synthetic and natural antagonists
Delivery of potential natural disease-modifying osteoarthritis drugs: Beyond polyphenols and flavonoids
Exosomal PD-L1 in hepatocellular carcinoma: Immune evasion mechanisms, diagnostic value, and strategies for therapeutic targeting
Cancer cell migration under control of human cathelicidin LL-37
Leukemic stem cells as drivers of therapeutic resistance in acute myeloid leukemia
Aptamers in cancer therapy: Why has clinical translation lagged behind preclinical promise?
Targeting neutrophil extracellular traps in liver ischemia-reperfusion injury: From molecular mechanisms to pharmacological and translational opportunities
Effects of diet-modulated gut microbiota and microbial metabolites in atherosclerosis
Immune–endothelial crosstalk in cardiovascular inflammation: Canakinumab at the intersection of mechanism and precision therapy
Focused ultrasound mediated gene therapy for glioblastoma: A preclinical in vivo systematic review and meta-analysis
Breast cancer and carotenoid- A comprehensive review of relationship insights, evidence, mechanisms, and future perspective
Electrical conditioning strategies in myocardial ischemia-reperfusion injury
Orchestrating cell death and microenvironment: Natural products as multi-target modulators of pyroptosis in myocardial ischemia-reperfusion injury
Cannabidiol and diabetic heart disease: Mechanistic evidence and translational challenges
Branched-chain amino acids and innate immunity in metabolic disease: Mechanisms, paradox, and therapeutic opportunities
Sex differences in animal models of complex disorders: Affective disorders, type 2 diabetes mellitus and essential hypertension
Targeting human oncogenic viruses with CRISPR/Cas: New therapeutic opportunities and challenges
IL-13Rα2 in liver cancer: Endothelial target for precision therapy
Mechanistic insights and clinical implications of the S100 protein family in breast cancer
Novel theophylline oral drops for pediatric use and biological evaluation
Preclinical comparison of non-signaling domain in CD19 CAR T cell with interleukin-7 receptor alpha signaling domain
In vitro activity and moderate in vivo efficacy of a novel β-carboline derivative against acute Toxoplasma gondii tachyzoites
Demethyleneberberine alleviates cellular senescence of human fibroblasts by directly activating FEN1
Metformin enhances response to chemotherapy combined with immunotherapy in a triple negative breast cancer in vivo model
Phenotypic profiles for anticancer drug responses using tumor spheroids
Photoporation enables non-viral delivery of prime editing RNP complexes into human iPSC-derived cardiomyocytes for cardiac genome correction
EZH2 inhibition in resistant glioblastoma stem cells counteracts oxidative stress protection and triggers ferroptosis
JAK2 inhibition with baricitinib stunts growth and postnatal development in juvenile rats
From maternal nutrition to neonatal neuroprotection: Passion fruit stilbenes in hypoxia-ischemia
Cardiotoxicity of trametinib monotherapy in adults with neurofibromatosis type 1: Results from the TRAIN study
Resolvin D5n-3 DPA protects against lung injury by modulating the NLRP3 inflammasome and immune pathways
Novel L1CAM-antibody drug conjugates exert potent anti-tumor activity in preclinical models of even advanced pancreatic cancer
Carvacrol mitigates chronic social isolation stress–induced depressive-like phenotypes via Nrf2-dependent antioxidant defense and downregulation of NF-κB proinflammatory pathway
Analysis of the relationship between body composition and the pharmacokinetics of panitumumab in the treatment of localized squamous cell carcinoma of the anus – An ancillary study of the FFCD0904 phase I and II trial
Feruloyl substitution is associated with distinct neurogenic and metabolic signatures in cinnamoylquinic acid derivatives: An integrated transcriptomic–metabolomic analysis
[⁶⁸Ga]Ga-NYM052: Design, synthesis, preclinical characterization, and first-in-human evaluation of a novel radiotracer targeting fibroblast activation protein
Polyphenol-rich extract of Syzygium cumini (L.) Skeels leaves improves the metabolic profile and redox status of dexamethasone-induced diabetic rats
Regulation of bone homeostasis by denosumab and genistein in a human quadruple culture bone model identifies osteocytes as important mediators
Anticancer effects of salidroside on ovarian cancer carcinogenesis and molecular mechanism in mice
Reversible electroporation triggers the release of microvesicles affecting viability, migration, and adhesion of melanoma cells
Synthetic melanin as a bioinspired antioxidant: Modulating oxidative stress from 2D skin models to human skin validation
Behavioural, pharmacokinetic, and genetic evidence of a cannabidiol-oxycodone drug-drug interaction in mice
BMP4-driven morphogenetic reprogramming sustains EGFR-TKI resistance via SOX2 suppression and EMT activation
An alginate-based 3D cell culture model as a useful tool for melanoma drug testing
Combining CRISPR/Cas9-mediated TRAC knockout with mRNA-based CAR expression enables flexible generation of allogeneic CAR T cells
Decanoic acid in Crohn’s disease-associated complications: Antifibrotic effect mediated by PPARγ
Dose dependent paradoxical increases in DNA methylation, reductions in p16 expression, and changes in histone modifications in gastric cancer cells treated with DNMT inhibitors
Trans-cinnamaldehyde triggers stringent response-mediated virulence attenuation in pathogenic Escherichia coli
Aspirin reprograms platelet signaling and the intrahepatic microbiome to suppress RyR2-driven inflammation and fibrosis in preclinical chronic liver disease
Role of P2Y6 receptor in pulmonary arterial hypertension and vascular remodeling following cigarette smoke exposure in mice
Small peptides derived from the autoinhibitory XY linker of phospholipase C-β isoforms inhibit enzyme activity and reduce inflammation
Development of a 3D bioprinted human skin model for predictive toxicology
Fatty Acid Synthase (FASN) as a targeted therapeutic in acquired 5-fluorouracil resistance in pancreatic cancer
Ferroptosis as a novel alternative cell death model in Hashimoto´s thyroiditis
A multivalent TAT–arginine-biodynamer conjugate targeting the bacterial cell envelope via specific membrane interactions
Medical gas plasma modulates in vitro keratinocyte redox signaling and secretory profiles in actinic keratosis and squamous cell carcinoma
Icariin, astragaloside IV and puerarin mixture salvages synaptic loss by enhancing mitochondrial biogenesis: A multi-target strategy for Alzheimer’s disease therapy
Pharmacological inhibition of CDK9 counteracts neuroinflammatory impairments in sepsis-associated encephalopathy
Therapeutic potential of phytocannabinoids in depression and cognitive dysfunction: Evidence from preclinical models
Effective oral countermeasures against ionizing radiation-induced damage without hindering cancer radiotherapy
A metabolomics and lipidomics atlas of pulmonary large cell neuroendocrine carcinoma
Deoxycholic acid (DCA) alleviates LPS-induced inflammatory bone loss via modulating the “Gut-Bone” homeostasis
Dimethyl fumarate attenuates subcutaneous adipose tissue inflammation in psoriasis
Target-mediated drug disposition modeling of liraglutide in rats: Implications of target engagement for pharmacodynamic predictions
A novel colchicine-binding site inhibitor suppresses triple-negative breast cancer growth and metastasis and synergizes with anti-PD-L1 immunotherapy in an immunogenic cancer model
Estradiol replacement abolishes cardiovascular and intracranial changes induced by a high-fat diet in menopausal female rats
Steroidal-nitroxide hybrid sustains oxidative stress and enhances cisplatin efficacy in vitro across multiple cancer cell lines
Resveratrol induces molecular changes in cholesterol homeostasis in SAMP8 mice cerebellum
Lithium chloride alters Tau phosphorylation, kinase activity, and Rho GTPase signaling in cell models
A covalent resveratrol-nitroxide conjugate protects against oxidative stress-induced cellular senescence
Multi-strain probiotic enhances metformin tolerance by modulating gut microbiome and bile acid pathways: Insight from multi-omics post-hoc analysis (ProGasMet trial)
Corrigendum “IRAS/Nischarin modulates morphine reward by glutamate receptor activation in the nucleus accumbens of mouse brain” [Biomed. Pharmacother. 153 (2022) 113346]
Corrigendum “Withania somnifera influences MDMA-induced hyperthermic, cognitive, neurotoxic and neuroinflammatory effects in mice.” [Biomed. Pharmacother. 161 (2023) 114475]
Corrigendum “The Chinese herbal medicine Fufang Zhenzhu Tiaozhi ameliorates diabetic cardiomyopathy by regulating cardiac abnormal lipid metabolism and mitochondrial dynamics in diabetic mice” [Biomed. Pharmacother. 164 (2023) 114919]
Corrigendum to “Platelet extracellular vesicles drive monocyte differentiation into inflammatory foam cells in peripheral arterial disease” [Biomed. & Pharmacother. 2026 (196) 119122]
Corrigendum “Investigating regulated signaling pathways in therapeutic targeting of non-small cell lung carcinoma” [Biomed. Pharmacother. 161 (2023) 114452]
Corrigendum “Adaptations in glutathione-based redox protein signaling pathways and alcohol drinking across species” [Biomed. Pharmacother. 180 (2024) 117514]
Corrigendum to “Entresto protected the cardiomyocytes and preserved heart function in cardiorenal syndrome rat fed with high-protein diet through regulating the oxidative stress and Mfn2-mediated mitochondrial functional integrity” [Biomed. Pharmacother. 144 (2021) 112244]
Corrigendum to “A fully human monoclonal antibody targeting Semaphorin 5A alleviates the progression of rheumatoid arthritis” [Biomed. Pharmacother. 168 (2023) 115666]
Corrigendum to “Revealment study on the regulation of lipid metabolism by Lingguizhugan Decoction in heart failure treatment based on integrated lipidomics and proteomics” [Biomed. Pharmacother. 158 (2023) 114066]
Corrigendum to “Hepatic inhibitors expression profiling of venom-challenged Sinonatrix annularis and antidotal activities” [Biomed. Pharmacother. 156 (2022) 113900]
Corrigendum to “Pectolinarigenin alleviated septic acute kidney injury via inhibiting Jak2/Stat3 signaling and mitochondria dysfunction” [Biomed. Pharmacother. 159 (2023) 114286]
Corrigendum to “Activation of α7nAch receptors ameliorates α-synuclein pathology in the brain and gut of a subacute MPTP mouse model of Parkinson's disease” [Biomed. Pharmacother. 184 (2025) 117871]
Corrigendum to “Enhancement of angiogenesis and neurogenesis by intracerebroventricular injection of secretome from human embryonic stem cell-derived mesenchymal stem cells in ischemic stroke model” [Biomed. Pharmacother. 140 (2021) 111709]
Corrigendum to “Lipid-based nanocarriers co-loaded with artemether and triglycerides of docosahexaenoic acid: Effects on human breast cancer cells” [Biomed. Pharmacother. 134 (2021) 111114]
Corrigendum to “IL-34 exacerbates pathogenic features of Alzheimers disease and calvaria osteolysis in triple transgenic (3x-Tg) female mice” [Biomed. Pharmacother. 166 (2023) 115435]
Corrigendum to “Bespoke doxorubicin-loaded gold nanoparticles for ultrasound-guided cancer cell killing” [Biomed. Pharmacother. 193 (2025) 118777]
Corrigendum “Development and optimization of paclitaxel-loaded Eudragit/PLGA nanoparticles by simplex lattice mixture design: Exploration of improved hemocompatibility and in vivo kinetics” [Biomed. Pharmacother. 144 (2021) 112286]
Corrigendum to “Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling” [Biomed. Pharmacother. 150 (2022) 112963]
Corrigendum “Activation of the IL-6/STAT3 pathway contributes to the pathogenesis of membranous nephropathy and is a target for Mahuang Fuzi and Shenzhuo Decoction MFSD to repair podocyte damage” [Biomed. & Pharmacother. 174 (2024) 116583]
Corrigendum to “The role of serine/threonine protein kinases in cardiovascular disease and potential therapeutic methods” [Biomed. Pharmacother. 177 (2024) 117093]
Corrigendum to “SDH, a novel diarylheptane compound, is a potential treatment for inflammatory bowel disease by restoring epithelial barrier function” [Biomed. Pharmacother. 151 (2022) 113080]
Corrigendum “Novel antidepressant mechanism of hypericin: Role of connexin 43-based gap junctions” [Biomed. Pharmacother. 167 (2023) 115545]
Corrigendum to “Galangin ameliorates severe acute pancreatitis in mice by activating the nuclear factor E2-related factor 2/heme oxygenase 1 pathway” [Biomed. Pharmacother. 144 (2021) 112293]
Corrigendum to “EnDuo, a novel derivative of Endostar, inhibits the migration of colon cancer cells, suppresses matrix metalloproteinase-2/9 expression and impedes AKT/ERK activation” [Biomed. Pharmacother. 134 (2021) 111136]
Corrigendum to “Gilteritinib reverses ABCB1-mediated multidrug resistance: Preclinical in vitro and animal investigations” [Biomed. Pharmacother. 180 (2024) 117603]
Corrigendum to “Ceftriaxone administration reduces vascular calcification associated with experimental models of chronic kidney disease.” [Biomed. Pharmacother. 197 (2026), 119131]
Retraction notice to "Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies" [Biomedicine & Pharmacotherapy 160 (2023) 114392]
Retraction notice to "Inhibition of non-muscular myosin light chain kinase accelerates the clearance of inflammatory cells by promoting the lysosome-mediated cell death" [Biomedicine & Pharmacotherapy 170 (2024) 115986]
Retraction notice to "Recent findings regarding the synergistic effects of emodin and its analogs with other bioactive compounds: Insights into new mechanisms" [Biomedicine & Pharmacotherapy 162 (2023) 114585]
Retraction notice to "New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities" [Biomedicine & Pharmacotherapy 141 (2021) 111824]
Retraction notice to "MicroRNA-98-HMGA2-POSTN signal pathway reverses epithelial-to-mesenchymal transition in laryngeal squamous cell carcinoma" [Biomedicine & Pharmacotherapy 117 (2019) 108998]
Retraction notice to "Kefir peptides mitigate L-NAME-induced preeclampsia in rats through modulating hypertension and endothelial dysfunction" [Biomedicine & Pharmacotherapy 180 (2024) 117592]
Retraction notice to "Innovative challenge for the inhibition of hepatocellular carcinoma progression by combined targeting of HSP90 and STAT3/HIF-1α signaling" [Biomedicine & Pharmacotherapy 158 (2023) 114196]
Retraction notice to "The α7 nAChR allosteric modulator PNU-120596 amends neuroinflammatory and motor consequences of parkinsonism in rats: Role of JAK2/NF-κB/GSk3β/ TNF-α pathway" [Biomedicine & Pharmacotherapy 148 (2022) 112776]
Retraction notice to "Verapamil attenuates oxidative stress and inflammatory responses in cigarette smoke (CS)-induced murine models of acute lung injury and CSE-stimulated RAW 264.7 macrophages via inhibiting the NF-κB pathway" [Biomedicine & Pharmacotherapy 149 (2022) 112783]
Retraction notice to "Evaluation of the hepatoprotective activity of hydroalcoholic extract of Alhagi camelorum against valproic acid-induced hepatotoxicity in rats" [Biomedicine & Pharmacotherapy 150 (2022) 112953]
Retraction notice to "Multiple strategies with the synergistic approach for addressing colorectal cancer" [Biomedicine & Pharmacotherapy 140 (2021) 111704]
Retraction notice to "Biochemical features and therapeutic potential of α-Mangostin: Mechanism of action, medicinal values, and health benefits" [Biomedicine & Pharmacotherapy 163 (2023) 114710]
Seuls les utilisateurs munis d'un compte client peuvent laisser un commentaire. Veuillez vous connecter ou créer un compte s'il vous plait.
product
https://www.elsevier-masson.fr/biomedicine-pharmacotherapy.html310920Biomedicine & Pharmacotherapyhttps://www.elsevier-masson.fr/media/catalog/product/y/b/ybm_1.jpg933933EURInStock/Autres disciplines/Biologie/Médecine/Biologie/Médecine/Biologie/Bactériologie/maladies infectieuses/Revues/Product Format/journals/Product Format/Journals/Product Format/Journals/Product Format/Journals/Product Format/Journals/Product Format/Revistas/Product Format/Zeitschrift2846357888285934440285265936792593984959398505939851593985259398536165527128204284622837159367913593680174535936778373593678274545936780105595936787278705936814An international multidisciplinary journal with two objectives :- to create an interface between clinical and laboratory responses to drugs and to investigate critical approaches to different pathologies with regard to biological and clinical data,- to provide a niche for authors whose work is not directly defined by the review criteria of existing journals. <strong><i>Biomedicine and pharmacotherapy</i></strong> is one of the few journals at the forefront of fundamental and technical science, biological and medical disciplines, therapeutics and pathological description. General fields of interest include molecular and cell biology, genetic disease, immunology and immunoregulation and chemotherapy. Special emphasis is placed on studies of specific topics such as differentiation, pharmacology and toxicology, preclinical and clinical pharmacology, the effects of drugs on cell structural and functional elements, the mechanism of gene regulation in normal and pathological cells, the role of viruses and parasites and the therapy of the diseases they induce. Brief reports of meetings, symposia and conferences will also be considered for publication as well as announcements of scientific meetings or academic courses.00148136Biomedicine & Pharmacotherapy933933https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueParticulierFrance (+ DOM-TOM)12 mois148137Biomedicine & Pharmacotherapy952.59952.59https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueParticulierUE (+ Suisse)12 mois148138Biomedicine & Pharmacotherapy933933https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueParticulierReste du monde12 mois148139Biomedicine & Pharmacotherapy933933https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueÉtudiantFrance (+ DOM-TOM)12 mois148140Biomedicine & Pharmacotherapy952.59952.59https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueÉtudiantUE (+ Suisse)12 mois148141Biomedicine & Pharmacotherapy933933https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueÉtudiantReste du monde12 mois148142Biomedicine & Pharmacotherapy10681068https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueInstitutionFrance (+ DOM-TOM)12 mois148143Biomedicine & Pharmacotherapy1155.771155.77https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueInstitutionUE (+ Suisse)12 mois148144Biomedicine & Pharmacotherapy13311331https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueInstitutionReste du monde12 mois148145Biomedicine & Pharmacotherapy18661866https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueParticulierFrance (+ DOM-TOM)24 mois148146Biomedicine & Pharmacotherapy1905.181905.18https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueParticulierUE (+ Suisse)24 mois148147Biomedicine & Pharmacotherapy18661866https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueParticulierReste du monde24 mois148148Biomedicine & Pharmacotherapy18661866https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueÉtudiantFrance (+ DOM-TOM)24 mois148149Biomedicine & Pharmacotherapy1905.181905.18https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueÉtudiantUE (+ Suisse)24 mois148150Biomedicine & Pharmacotherapy18661866https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueÉtudiantReste du monde24 mois148151Biomedicine & Pharmacotherapy21362136https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueInstitutionFrance (+ DOM-TOM)24 mois148152Biomedicine & Pharmacotherapy2311.542311.54https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueInstitutionUE (+ Suisse)24 mois148153Biomedicine & Pharmacotherapy26622662https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueInstitutionReste du monde24 mois148154Biomedicine & Pharmacotherapy27992799https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueParticulierFrance (+ DOM-TOM)36 mois148155Biomedicine & Pharmacotherapy2857.772857.77https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueParticulierUE (+ Suisse)36 mois148156Biomedicine & Pharmacotherapy27992799https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueParticulierReste du monde36 mois148157Biomedicine & Pharmacotherapy27992799https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueÉtudiantFrance (+ DOM-TOM)36 mois148158Biomedicine & Pharmacotherapy2857.772857.77https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueÉtudiantUE (+ Suisse)36 mois148159Biomedicine & Pharmacotherapy27992799https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueÉtudiantReste du monde36 mois148160Biomedicine & Pharmacotherapy32043204https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueInstitutionFrance (+ DOM-TOM)36 mois148161Biomedicine & Pharmacotherapy3467.313467.31https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueInstitutionUE (+ Suisse)36 mois148162Biomedicine & Pharmacotherapy39933993https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueInstitutionReste du monde36 mois2011 and earlier1Revue210 x 280 mmELSEVIER1 janv. 1956EN STOCK19810 n° par anRevueAnglaisRevue - Numériquehttp://www.em-consulte.com/produit/biophaNonEditorial Board | Targeted cytosolic delivery of mRNA immunotherapeutics: From vaccine delivery to protein replacement | Immune checkpoint targeted drug conjugate therapies: Bridging preclinical and clinical innovation for solid tumor therapy | Beyond total release: Fragment-resolved metrics for ultrasound microbubble-mediated drug delivery | Targeting NLRP3 inflammasome signaling for atrial fibrillation therapy | Cell death in kidney transplantation: Mechanisms and therapeutic perspectives | Advancing adoptive cellular immunotherapy via Notch-based <i>ex vivo</i> T cell development platforms | Adipose stem cell-derived exosomes as emerging neurotherapeutics in obesity induced diabetic neuropathy | Lipidomic insights into infectious meningitis: Pathogen-specific alterations and therapeutic implications | Injectable thermosensitive hydrogel-based sustained delivery system for anti-diabetic peptides in type 2 diabetes mellitus therapy: A review | The trophoblastic theory of cancer: Progesterone-dependent immune tolerance and modulation by synthetic and natural antagonists | Delivery of potential natural disease-modifying osteoarthritis drugs: Beyond polyphenols and flavonoids | Exosomal PD-L1 in hepatocellular carcinoma: Immune evasion mechanisms, diagnostic value, and strategies for therapeutic targeting | Cancer cell migration under control of human cathelicidin LL-37 | Leukemic stem cells as drivers of therapeutic resistance in acute myeloid leukemia | Aptamers in cancer therapy: Why has clinical translation lagged behind preclinical promise? | Targeting neutrophil extracellular traps in liver ischemia-reperfusion injury: From molecular mechanisms to pharmacological and translational opportunities | Effects of diet-modulated gut microbiota and microbial metabolites in atherosclerosis | Immune–endothelial crosstalk in cardiovascular inflammation: Canakinumab at the intersection of mechanism and precision therapy | Focused ultrasound mediated gene therapy for glioblastoma: A preclinical <i>in vivo</i> systematic review and meta-analysis | Breast cancer and carotenoid- A comprehensive review of relationship insights, evidence, mechanisms, and future perspective | Electrical conditioning strategies in myocardial ischemia-reperfusion injury | Orchestrating cell death and microenvironment: Natural products as multi-target modulators of pyroptosis in myocardial ischemia-reperfusion injury | Cannabidiol and diabetic heart disease: Mechanistic evidence and translational challenges | Branched-chain amino acids and innate immunity in metabolic disease: Mechanisms, paradox, and therapeutic opportunities | Sex differences in animal models of complex disorders: Affective disorders, type 2 diabetes mellitus and essential hypertension | Targeting human oncogenic viruses with CRISPR/Cas: New therapeutic opportunities and challenges | IL-13Rα2 in liver cancer: Endothelial target for precision therapy | Mechanistic insights and clinical implications of the S100 protein family in breast cancer | Novel theophylline oral drops for pediatric use and biological evaluation | Preclinical comparison of non-signaling domain in CD19 CAR T cell with interleukin-7 receptor alpha signaling domain | In vitro activity and moderate in vivo efficacy of a novel <i>β</i>-carboline derivative against acute Toxoplasma gondii tachyzoites | Demethyleneberberine alleviates cellular senescence of human fibroblasts by directly activating FEN1 | Metformin enhances response to chemotherapy combined with immunotherapy in a triple negative breast cancer <i>in vivo</i> model | Phenotypic profiles for anticancer drug responses using tumor spheroids | Photoporation enables non-viral delivery of prime editing RNP complexes into human iPSC-derived cardiomyocytes for cardiac genome correction | EZH2 inhibition in resistant glioblastoma stem cells counteracts oxidative stress protection and triggers ferroptosis | JAK2 inhibition with baricitinib stunts growth and postnatal development in juvenile rats | From maternal nutrition to neonatal neuroprotection: Passion fruit stilbenes in hypoxia-ischemia | Cardiotoxicity of trametinib monotherapy in adults with neurofibromatosis type 1: Results from the TRAIN study | Resolvin D5<sub>n-3 DPA</sub> protects against lung injury by modulating the NLRP3 inflammasome and immune pathways | Novel L1CAM-antibody drug conjugates exert potent anti-tumor activity in preclinical models of even advanced pancreatic cancer | Carvacrol mitigates chronic social isolation stress–induced depressive-like phenotypes via Nrf2-dependent antioxidant defense and downregulation of NF-κB proinflammatory pathway | Analysis of the relationship between body composition and the pharmacokinetics of panitumumab in the treatment of localized squamous cell carcinoma of the anus – An ancillary study of the FFCD0904 phase I and II trial | Feruloyl substitution is associated with distinct neurogenic and metabolic signatures in cinnamoylquinic acid derivatives: An integrated transcriptomic–metabolomic analysis | [⁶⁸Ga]Ga-NYM052: Design, synthesis, preclinical characterization, and first-in-human evaluation of a novel radiotracer targeting fibroblast activation protein | Polyphenol-rich extract of <i>Syzygium cumini</i> (L.) Skeels leaves improves the metabolic profile and redox status of dexamethasone-induced diabetic rats | Regulation of bone homeostasis by denosumab and genistein in a human quadruple culture bone model identifies osteocytes as important mediators | Anticancer effects of salidroside on ovarian cancer carcinogenesis and molecular mechanism in mice | Reversible electroporation triggers the release of microvesicles affecting viability, migration, and adhesion of melanoma cells | Synthetic melanin as a bioinspired antioxidant: Modulating oxidative stress from 2D skin models to human skin validation | Behavioural, pharmacokinetic, and genetic evidence of a cannabidiol-oxycodone drug-drug interaction in mice | BMP4-driven morphogenetic reprogramming sustains EGFR-TKI resistance via SOX2 suppression and EMT activation | An alginate-based 3D cell culture model as a useful tool for melanoma drug testing | Combining CRISPR/Cas9-mediated TRAC knockout with mRNA-based CAR expression enables flexible generation of allogeneic CAR T cells | Decanoic acid in Crohn’s disease-associated complications: Antifibrotic effect mediated by PPARγ | Dose dependent paradoxical increases in DNA methylation, reductions in p16 expression, and changes in histone modifications in gastric cancer cells treated with DNMT inhibitors | <i>Trans</i>-cinnamaldehyde triggers stringent response-mediated virulence attenuation in pathogenic <i>Escherichia coli</i> | Aspirin reprograms platelet signaling and the intrahepatic microbiome to suppress RyR2-driven inflammation and fibrosis in preclinical chronic liver disease | Role of P2Y6 receptor in pulmonary arterial hypertension and vascular remodeling following cigarette smoke exposure in mice | Small peptides derived from the autoinhibitory XY linker of phospholipase C-β isoforms inhibit enzyme activity and reduce inflammation | Development of a 3D bioprinted human skin model for predictive toxicology | Fatty Acid Synthase (FASN) as a targeted therapeutic in acquired 5-fluorouracil resistance in pancreatic cancer | Ferroptosis as a novel alternative cell death model in Hashimoto´s thyroiditis | A multivalent TAT–arginine-biodynamer conjugate targeting the bacterial cell envelope via specific membrane interactions | Medical gas plasma modulates in vitro keratinocyte redox signaling and secretory profiles in actinic keratosis and squamous cell carcinoma | Icariin, astragaloside IV and puerarin mixture salvages synaptic loss by enhancing mitochondrial biogenesis: A multi-target strategy for Alzheimer’s disease therapy | Pharmacological inhibition of CDK9 counteracts neuroinflammatory impairments in sepsis-associated encephalopathy | Therapeutic potential of phytocannabinoids in depression and cognitive dysfunction: Evidence from preclinical models | Effective oral countermeasures against ionizing radiation-induced damage without hindering cancer radiotherapy | A metabolomics and lipidomics atlas of pulmonary large cell neuroendocrine carcinoma | Deoxycholic acid (DCA) alleviates LPS-induced inflammatory bone loss via modulating the “Gut-Bone” homeostasis | Dimethyl fumarate attenuates subcutaneous adipose tissue inflammation in psoriasis | Target-mediated drug disposition modeling of liraglutide in rats: Implications of target engagement for pharmacodynamic predictions | A novel colchicine-binding site inhibitor suppresses triple-negative breast cancer growth and metastasis and synergizes with anti-PD-L1 immunotherapy in an immunogenic cancer model | Estradiol replacement abolishes cardiovascular and intracranial changes induced by a high-fat diet in menopausal female rats | Steroidal-nitroxide hybrid sustains oxidative stress and enhances cisplatin efficacy in vitro across multiple cancer cell lines | Resveratrol induces molecular changes in cholesterol homeostasis in SAMP8 mice cerebellum | Lithium chloride alters Tau phosphorylation, kinase activity, and Rho GTPase signaling in cell models | A covalent resveratrol-nitroxide conjugate protects against oxidative stress-induced cellular senescence | Multi-strain probiotic enhances metformin tolerance by modulating gut microbiome and bile acid pathways: Insight from multi-omics post-hoc analysis (ProGasMet trial) | Corrigendum “IRAS/Nischarin modulates morphine reward by glutamate receptor activation in the nucleus accumbens of mouse brain” [Biomed. Pharmacother. 153 (2022) 113346] | Corrigendum “Withania somnifera influences MDMA-induced hyperthermic, cognitive, neurotoxic and neuroinflammatory effects in mice.” [Biomed. Pharmacother. 161 (2023) 114475] | Corrigendum “The Chinese herbal medicine Fufang Zhenzhu Tiaozhi ameliorates diabetic cardiomyopathy by regulating cardiac abnormal lipid metabolism and mitochondrial dynamics in diabetic mice” [Biomed. Pharmacother. 164 (2023) 114919] | Corrigendum to “Platelet extracellular vesicles drive monocyte differentiation into inflammatory foam cells in peripheral arterial disease” [Biomed. & Pharmacother. 2026 (196) 119122] | Corrigendum “Investigating regulated signaling pathways in therapeutic targeting of non-small cell lung carcinoma” [Biomed. Pharmacother. 161 (2023) 114452] | Corrigendum “Adaptations in glutathione-based redox protein signaling pathways and alcohol drinking across species” [Biomed. Pharmacother. 180 (2024) 117514] | Corrigendum to “Entresto protected the cardiomyocytes and preserved heart function in cardiorenal syndrome rat fed with high-protein diet through regulating the oxidative stress and Mfn2-mediated mitochondrial functional integrity” [Biomed. Pharmacother. 144 (2021) 112244] | Corrigendum to “A fully human monoclonal antibody targeting Semaphorin 5A alleviates the progression of rheumatoid arthritis” [Biomed. Pharmacother. 168 (2023) 115666] | Corrigendum to “Revealment study on the regulation of lipid metabolism by Lingguizhugan Decoction in heart failure treatment based on integrated lipidomics and proteomics” [Biomed. Pharmacother. 158 (2023) 114066] | Corrigendum to “Hepatic inhibitors expression profiling of venom-challenged Sinonatrix annularis and antidotal activities” [Biomed. Pharmacother. 156 (2022) 113900] | Corrigendum to “Pectolinarigenin alleviated septic acute kidney injury via inhibiting Jak2/Stat3 signaling and mitochondria dysfunction” [Biomed. Pharmacother. 159 (2023) 114286] | Corrigendum to “Activation of α7nAch receptors ameliorates α-synuclein pathology in the brain and gut of a subacute MPTP mouse model of Parkinson's disease” [Biomed. Pharmacother. 184 (2025) 117871] | Corrigendum to “Enhancement of angiogenesis and neurogenesis by intracerebroventricular injection of secretome from human embryonic stem cell-derived mesenchymal stem cells in ischemic stroke model” [Biomed. Pharmacother. 140 (2021) 111709] | Corrigendum to “Lipid-based nanocarriers co-loaded with artemether and triglycerides of docosahexaenoic acid: Effects on human breast cancer cells” [Biomed. Pharmacother. 134 (2021) 111114] | Corrigendum to “IL-34 exacerbates pathogenic features of Alzheimers disease and calvaria osteolysis in triple transgenic (3x-Tg) female mice” [Biomed. Pharmacother. 166 (2023) 115435] | Corrigendum to “Bespoke doxorubicin-loaded gold nanoparticles for ultrasound-guided cancer cell killing” [Biomed. Pharmacother. 193 (2025) 118777] | Corrigendum “Development and optimization of paclitaxel-loaded Eudragit/PLGA nanoparticles by simplex lattice mixture design: Exploration of improved hemocompatibility and in vivo kinetics” [Biomed. Pharmacother. 144 (2021) 112286] | Corrigendum to “Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling” [Biomed. Pharmacother. 150 (2022) 112963] | Corrigendum “Activation of the IL-6/STAT3 pathway contributes to the pathogenesis of membranous nephropathy and is a target for Mahuang Fuzi and Shenzhuo Decoction MFSD to repair podocyte damage” [Biomed. & Pharmacother. 174 (2024) 116583] | Corrigendum to “The role of serine/threonine protein kinases in cardiovascular disease and potential therapeutic methods” [Biomed. Pharmacother. 177 (2024) 117093] | Corrigendum to “SDH, a novel diarylheptane compound, is a potential treatment for inflammatory bowel disease by restoring epithelial barrier function” [Biomed. Pharmacother. 151 (2022) 113080] | Corrigendum “Novel antidepressant mechanism of hypericin: Role of connexin 43-based gap junctions” [Biomed. Pharmacother. 167 (2023) 115545] | Corrigendum to “Galangin ameliorates severe acute pancreatitis in mice by activating the nuclear factor E2-related factor 2/heme oxygenase 1 pathway” [Biomed. Pharmacother. 144 (2021) 112293] | Corrigendum to “EnDuo, a novel derivative of Endostar, inhibits the migration of colon cancer cells, suppresses matrix metalloproteinase-2/9 expression and impedes AKT/ERK activation” [Biomed. Pharmacother. 134 (2021) 111136] | Corrigendum to “Gilteritinib reverses ABCB1-mediated multidrug resistance: Preclinical in vitro and animal investigations” [Biomed. Pharmacother. 180 (2024) 117603] | Corrigendum to Anisamide-conjugated hairpin antisense oligonucleotides prodrug co-delivering doxorubicin exhibited enhanced anticancer efficacy [BIOPHA, 173 (2024) 116390] | Corrigendum to “Ceftriaxone administration reduces vascular calcification associated with experimental models of chronic kidney disease.” [Biomed. Pharmacother. 197 (2026), 119131] | Retraction notice to "Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies" [Biomedicine & Pharmacotherapy 160 (2023) 114392] | Retraction notice to "Inhibition of non-muscular myosin light chain kinase accelerates the clearance of inflammatory cells by promoting the lysosome-mediated cell death" [Biomedicine & Pharmacotherapy 170 (2024) 115986] | Retraction notice to "Recent findings regarding the synergistic effects of emodin and its analogs with other bioactive compounds: Insights into new mechanisms" [Biomedicine & Pharmacotherapy 162 (2023) 114585] | Retraction notice to "New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities" [Biomedicine & Pharmacotherapy 141 (2021) 111824] | Retraction notice to "MicroRNA-98-HMGA2-POSTN signal pathway reverses epithelial-to-mesenchymal transition in laryngeal squamous cell carcinoma" [Biomedicine & Pharmacotherapy 117 (2019) 108998] | Retraction notice to "Kefir peptides mitigate L-NAME-induced preeclampsia in rats through modulating hypertension and endothelial dysfunction" [Biomedicine & Pharmacotherapy 180 (2024) 117592] | Retraction notice to "Innovative challenge for the inhibition of hepatocellular carcinoma progression by combined targeting of HSP90 and STAT3/HIF-1α signaling" [Biomedicine & Pharmacotherapy 158 (2023) 114196] | Retraction notice to "The α7 nAChR allosteric modulator PNU-120596 amends neuroinflammatory and motor consequences of parkinsonism in rats: Role of JAK2/NF-κB/GSk3β/ TNF-α pathway" [Biomedicine & Pharmacotherapy 148 (2022) 112776] | Retraction notice to "Verapamil attenuates oxidative stress and inflammatory responses in cigarette smoke (CS)-induced murine models of acute lung injury and CSE-stimulated RAW 264.7 macrophages via inhibiting the NF-κB pathway" [Biomedicine & Pharmacotherapy 149 (2022) 112783] | Retraction notice to "Evaluation of the hepatoprotective activity of hydroalcoholic extract of <i>Alhagi camelorum</i> against valproic acid-induced hepatotoxicity in rats" [Biomedicine & Pharmacotherapy 150 (2022) 112953] | Retraction notice to "Multiple strategies with the synergistic approach for addressing colorectal cancer" [Biomedicine & Pharmacotherapy 140 (2021) 111704] | Retraction notice to "Biochemical features and therapeutic potential of α-Mangostin: Mechanism of action, medicinal values, and health benefits" [Biomedicine & Pharmacotherapy 163 (2023) 114710]Cmai 2026Revue - Numérique<ul><li>10 n° par an </li><li>Application iPhone/iPad</li><li>Début de l'abonnement : maximum 48h après réception du paiement.</li></ul>NonNonNonNonVeuillez sélectionnerVeuillez sélectionnerNonNonVeuillez sélectionner
